Reduced-Toxicity Conditioning Treatments: What Clinicians Need to Know Now

WEBINAR 1: Patient Selection and Comparative Regimen Review (30 minutes)
This session addresses the critical decision-making process in conditioning regimen selection. Faculty will outline criteria for identifying appropriate candidates for reduced-toxicity conditioning versus myeloablative approaches, followed by a comprehensive review of current reduced-toxicity regimens. The presentation compares efficacy outcomes and safety profiles across regimens, with direct application to clinical practice through a complex AML/MDS case presentation that demonstrates real-world decision-making principles.

WEBINAR 2: Prevention and Monitoring Strategies for Treatment-Related Adverse Events (30 minutes)
This session focuses on proactive approaches to minimize complications associated with reduced-toxicity conditioning. Faculty will present strategies for pre-transplant risk assessment, evidence-based monitoring protocols, prevention strategies, and structured management algorithms for key complications that may arise during and after conditioning.

WEBINAR 3: Interactive Case Discussion and Clinical Application (30 minutes)
This session reinforces learning through interactive case-based discussion. Faculty will guide participants through complex clinical scenarios, highlighting how to apply patient selection criteria, choose appropriate regimens, and implement monitoring and management strategies in real-world settings. The session concludes with expert commentary on emerging best practices and evolving approaches to optimizing patient outcomes.

Additional information regarding speakers and accreditation can be found within each webinar.

This educational program was made possible through a generous educational grant from Medexus.